한글목차

세계 주사용 혈청 고나도트로핀(주사용 혈청 성선자극호르몬) 시장은 유망하며, 돼지, 소, 양, 말 시장에서 기회가 있습니다. 주사용 혈청 고나도트로핀 세계 시장은 2025년부터 2031년까지 연평균 5.7%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 전 세계 불임의 확산과 보조생식술에 대한 수요 증가입니다.

• Lucintel의 예측에 따르면, 종류별로는 1000IU/병이 예측 기간 동안 높은 성장을 이룰 것으로 예상됩니다.
• 용도별로는 돼지가 가장 높은 성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장을 보일 것으로 예상됩니다.

주사용 혈청 고나도트로핀 시장의 전략적 성장 기회

주사용 혈청 고나도트로핀 시장은 다양한 용도의 다양한 분야에서 전략적 성장 잠재력을 가지고 있습니다. 불임 치료에 대한 높은 수요로 인해 이해관계자들은 이러한 성장 기회를 활용하여 시장 진입을 늘리고 환자 수요를 효과적으로 충족시킬 수 있습니다.

• 신흥 시장 진출 : 신흥 시장, 특히 아시아와 아프리카는 혈청 고나도트로핀 주사의 성장에 유리한 기회를 제공합니다. 불임으로 고통받는 많은 환자들이 불임 치료 서비스 및 교육에 대한 접근성 향상으로 혜택을 받을 수 있기 때문에 이들 지역은 시장 확대에 중요한 역할을 할 수 있습니다.
• 병용요법 개발 : 혈청 고나도트로핀은 다른 불임 치료제와 병용하여 치료 효과를 높일 수 있습니다. 이를 통해 의료진은 복잡한 사례에 대해 종합적인 치료를 제공할 수 있어 불임 치료 서비스의 질을 향상시킬 수 있습니다.
• 환자 중심 서비스에 대한 투자 : 환자 교육 및 환자 중심 솔루션에 중점을 둔 조직은 향후에도 경쟁 우위를 유지할 수 있습니다. 환자가 치료를 이해하고 관리할 수 있는 리소스를 제공하면 신뢰가 쌓이고, 순응도가 높아지며, 시장에서의 입지가 강화됩니다.
• 연구개발에 집중 : LHRH 및 hCG와 같은 혈청 고나도트로핀 제제를 항상 최신 상태로 유지하는 것은 경쟁력을 유지하는 데 필수적입니다. 혼잡한 시장에서 기업은 기존 제품의 용도를 추가 개발하고 현재 제품을 강화함으로써 우위를 점할 수 있습니다.
• 커넥티드 케어 기술 활용 : 치료 관리를 위한 모바일 애플리케이션과 같은 기술의 통합은 환자의 참여를 높일 수 있습니다. 이러한 추세는 새로운 시장 기회를 창출하고, 기업들은 치료 과정 전반에 걸쳐 환자를 지원하는 종합적인 솔루션을 제공할 수 있게 됩니다.

이러한 전략적 성장 기회는 주사제 혈청 고나도트로핀 분야에서 기술 혁신, 환자 중심, 시장 변화에 대한 대응력이 필요함을 강조하고 있습니다.

주사용 혈청 고나도트로핀 시장 촉진요인 및 과제

주사용 혈청 고나도트로핀 시장은 다양한 기술적, 경제적, 규제적 요인에 의해 크게 영향을 받습니다. 변화하는 시장 환경에서 성공하기 위해서는 이해관계자들이 이러한 동향을 이해하는 것이 매우 중요합니다.

주사용 혈청 고나도트로핀 시장을 이끄는 요인은 다음과 같습니다:

• 불임률 증가 : 불임률 증가 : 불임률 증가는 치료 옵션을 찾는 사람들이 증가함에 따라 주사 가능한 혈청 고나도트로핀에 대한 수요를 창출하고 있습니다. 이러한 수요는 주사제 제품 공급을 확대하는 기업들에 힘을 실어주고 있습니다.
• 생식기술의 발전 : 체외수정 및 미세수정과 같은 기술 혁신은 혈청 고나도트로핀에 대한 수요를 촉진하고 있습니다. 이러한 발전은 환자들에게 다양한 치료 옵션을 제공하며 시장 성장에 기여하고 있습니다.
• 불임 치료의 수용 확대 : 불임 치료에 대한 사회적 수용이 증가함에 따라 더 많은 사람들이 도움을 요청하게 되었고, 그 결과 혈청 고나도트로핀 주사의 처방률이 증가하여 시장 기회가 확대되고 있습니다.
• 생식 보건에 대한 정부 지원 : 많은 정부가 불임 치료를 포함한 생식 보건에 대한 예산 배분을 늘리고 있습니다. 이러한 지원은 인식 제고뿐만 아니라 혈청 고나도트로핀 요법에 대한 접근성을 개선하고 시장 성장을 촉진할 수 있습니다.

주사용 혈청 고나도트로핀 시장의 과제는 다음과 같습니다:

• 규제 준수 및 비용 : 규제 요건에 대한 대응은 제조 비용 상승, 제품 출시 지연, 시장 성장의 걸림돌, 신제품 도입의 제한을 초래할 수 있습니다.
• 시장 포화 및 가격 압력 : 혈청 고나도트로핀 시장에 진입하는 기업이 늘어나면서 경쟁이 심화되고 있습니다. 이러한 포화 상태는 가격 인하로 이어져 제조업체의 수익성과 지속가능성에 영향을 미칠 수 있습니다.
• 치료 효과에 대한 우려 : 일부 환자들은 혈청 고나도트로핀 주사의 효과에 의문을 제기하고, 치료를 받는 것을 주저할 수 있습니다. 교육이나 조사를 통해 이러한 우려를 해소하는 것은 환자의 신뢰와 수용을 구축하는 데 도움이 될 수 있습니다.

주사용 혈청 고나도트로핀 시장 진입 기업 목록

이 시장의 기업들은 제공하는 제품의 품질에 따라 경쟁하고 있습니다. 이 시장의 주요 기업들은 제조 시설 확장, R&D 투자, 인프라 개발, 밸류체인 전반의 통합 기회 활용에 주력하고 있습니다. 이러한 전략을 통해 주사제 혈청 고나도트로핀 시장은 수요 증가에 대응하고, 경쟁력을 확보하고, 혁신적인 제품과 기술을 개발하며, 생산 비용을 절감하고, 고객 기반을 확장하고 있습니다. 본 보고서에 수록된 혈청 고나도트로핀 기업 개요는 다음과 같습니다.

• MSD Animal Health
• Ceva Sante Animale
• Syntex
• Bioveta
• Ningbo Sansheng Biological Technology
• Ningbo Second Hormone Factory
• Chifeng Bo-En Pharmaceutical
• Guangzhou Vbio-Pharma
• JALLY
• Ningbo Creator Animal Pharmaceutical

목차

제1장 주요 요약

제2장 세계의 주사용 혈청 고나도트로핀 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 주사용 혈청 고나도트로핀 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 주사용 혈청 고나도트로핀 시장 : 종류별
  • 1000 IU/단위
  • 5000 IU/단위
  • 기타
• 세계의 주사용 혈청 고나도트로핀 시장 : 용도별
  • 돼지
  • 소
  • 양
  • 말
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 주사용 혈청 고나도트로핀 시장 : 지역별
• 북미의 주사용 혈청 고나도트로핀 시장
• 유럽의 주사용 혈청 고나도트로핀 시장
• 아시아태평양의 주사용 혈청 고나도트로핀 시장
• 기타 지역의 주사용 혈청 고나도트로핀 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 주사용 혈청 고나도트로핀 시장 성장 기회 : 종류별
  • 세계의 주사용 혈청 고나도트로핀 시장 성장 기회 : 용도별
  • 세계의 주사용 혈청 고나도트로핀 시장 성장 기회 : 지역별
• 세계의 주사용 혈청 고나도트로핀 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 주사용 혈청 고나도트로핀 시장 생산능력 확대
  • 세계의 주사용 혈청 고나도트로핀 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• MSD Animal Health
• Ceva Sante Animale
• Syntex
• Bioveta
• Ningbo Sansheng Biological Technology
• Ningbo Second Hormone Factory
• Chifeng Bo-En Pharmaceutical
• Guangzhou Vbio-Pharma
• JALLY
• Ningbo Creator Animal Pharmaceutical

영문목차

The future of the global serum gonadotrophin for injection market looks promising, with opportunities in the pig, cattle, sheep, and horse markets. The global serum gonadotrophin for injection market is expected to grow with a CAGR of 5.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of infertility issues worldwide and the growing demand for assisted reproductive technologies.

• Lucintel forecasts that, within the type category, 1000 IU/unit is expected to witness higher growth over the forecast period.
• Within the application category, pig is expected to witness the highest growth.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our 150+ page report.

Emerging Trends in the Serum Gonadotrophin for Injection Market

The serum gonadotrophin for injection market is witnessing several emerging trends that reflect its forward-looking orientation. These trends indicate that reproductive health and fertility-related services are evolving due to changes in patient needs and technological advancements. Stakeholders must understand these trends to capitalize on growth opportunities.

• Trend Towards Customized Therapies: The move toward personalized medicine is accelerating within the serum gonadotrophin market. This trend enhances treatment success by addressing the holistic needs of patients and improving overall patient care.
• Rising Adoption of Biosimilars: The availability of biosimilar gonadotrophins is altering market dynamics. These alternatives offer cost-effective solutions for patients, driving competition and encouraging manufacturers to innovate and reduce treatment costs.
• Increased Use of Telemedicine for Fertility Treatments: Advances in telemedicine are changing how serum gonadotrophins are administered. Telemedicine extends access to treatment, especially for patients in remote areas, making fertility care more accessible and affordable.
• Focus on Education and Awareness: Demand for serum gonadotrophin injections is increasing as efforts to educate patients about reproductive health and fertility treatments intensify. Greater awareness encourages early treatment, positively impacting market growth.
• Regulatory Support for Innovation: Regulatory agencies are increasingly supporting advancements in serum gonadotrophin formulations and shortening approval timelines. This support fosters competition by expediting the launch of new products, providing more treatment options for patients.

These trends are guiding the serum gonadotrophin for injection market toward more accessible, innovative, and effective fertility treatments.

Recent Developments in the Serum Gonadotrophin for Injection Market

The serum gonadotrophin for injection market is undergoing rapid changes driven by developments aimed at enhancing market penetration for fertility treatments. These changes stem from evolving trends in treatments, regulations, and product development that address growing societal needs for effective fertility solutions.

• Introduction of Novel Formulations: Recent innovations include the development of new serum gonadotrophins with improved bioavailability and efficacy. These formulations aim to enhance the success rates for patients undergoing assisted reproductive technology by improving therapeutic effectiveness.
• Expansion of Clinical Applications: Serum gonadotrophins are being applied to a broader range of fertility treatments. This diversification creates new opportunities for manufacturers and increases overall demand for these therapies.
• Research and Development Partnerships: Pharmaceutical companies and research institutions are increasingly collaborating on new serum gonadotrophin products. These partnerships capitalize on synergies to drive productivity and innovation.
• Adoption of Advanced Delivery Methods: There is a growing demand for modern serum gonadotrophin delivery systems, such as prefilled syringes and pen devices. These innovations enhance patient convenience and compliance, leading to improved treatment outcomes.
• Regulatory Advances for Faster Approvals: Regulatory bodies are expediting approvals for new serum gonadotrophin formulations, facilitating the market entry of new treatments. This trend is expected to boost competition and expand treatment options for healthcare providers and patients.

These recent developments reflect the dynamic nature of the injectable serum gonadotrophin market, which is evolving with the help of new technologies, collaborations, and regulatory advancements.

Strategic Growth Opportunities for Serum Gonadotrophin for Injection Market

Strategic growth potential can be seen in various areas of the serum gonadotrophin for injection market across different applications. Given the high demand for fertility treatments, stakeholders can leverage these growth opportunities to increase market participation and effectively meet patient demands.

• Expansion into Emerging Markets: Emerging markets, particularly in Asia and Africa, offer favorable opportunities for the growth of serum gonadotrophin injections. Many patients struggling with infertility will benefit from increased access to fertility services and education, making these regions valuable for market expansion.
• Development of Combination Therapies: Serum gonadotrophins can be combined with other fertility drugs to enhance treatment outcomes. This allows healthcare providers to offer comprehensive treatments for complex cases, improving the quality of fertility services.
• Investment in Patient-Centric Services: Organizations focusing on patient education and patient-centered solutions will continue to have a competitive advantage. Providing resources to help patients understand and manage their treatment builds confidence, improves adherence, and strengthens market presence.
• Focus on Research and Development: It is essential to keep serum gonadotrophin products, such as LHRH and hCG, up-to-date to remain competitive. In a crowded market, companies can gain an edge by developing additional applications for existing products and enhancing current offerings.
• Utilizing Connective Care Technologies: The integration of technologies, such as mobile applications for treatment management, can increase patient engagement. This trend creates new market opportunities, allowing companies to offer comprehensive solutions that support patients throughout the treatment process.

These strategic growth opportunities emphasize the need for innovation, patient orientation, and responsiveness to market evolution in the serum gonadotrophin for injection sector.

Serum Gonadotrophin for Injection Market Driver and Challenges

The serum gonadotrophin for injection market is significantly influenced by various technological, economic, and regulatory factors. Understanding these trends is crucial for stakeholders looking to succeed amid evolving market conditions.

The factors driving the serum gonadotrophin for injection market include:

• Increasing Infertility Rates: Rising infertility rates have created demand for injectable serum gonadotrophins as more people seek treatment options. This need is encouraging companies to expand their offerings of injectable products.
• Advancements in Reproductive Technologies: Innovations such as IVF and ICSI are driving demand for serum gonadotrophins. These advancements provide broader treatment options for patients, contributing to market growth.
• Increasing Acceptance of Fertility Treatment: With growing social acceptance of fertility treatments, more people are seeking help, resulting in higher prescription rates for serum gonadotrophin injections and expanding market opportunities.
• Government Support for Reproductive Health: Many governments are increasing budget allocations for reproductive health initiatives, including infertility treatment. This support not only raises awareness but also improves access to serum gonadotrophin therapies, fostering market growth.

Challenges in the serum gonadotrophin for injection market are:

• Regulatory Compliance and Cost: Complying with regulatory requirements may increase production costs and delay product launches, posing obstacles to market growth and limiting the introduction of new products.
• Market Saturation and Pricing Pressure: With more players entering the serum gonadotrophin market, competition is intensifying. This saturation can lead to price reductions, impacting profitability and sustainability for manufacturers.
• Concerns About Treatment Efficacy: Some patients may question the effectiveness of serum gonadotrophin injections, potentially causing hesitation in seeking treatment. Addressing these concerns through education and research can help build patient confidence and acceptance.

The drivers and challenges in the serum gonadotrophin for injection market highlight the need for a balanced strategy. Companies that align their operations with these trends while addressing market challenges will be well-positioned for long-term success in a competitive environment.

List of Serum Gonadotrophin Companies for Injection Market

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, serum gonadotrophin companies for the injection market cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the serum gonadotrophin companies for injection market profiled in this report include-

• MSD Animal Health
• Ceva Sante Animale
• Syntex
• Bioveta
• Ningbo Sansheng Biological Technology
• Ningbo Second Hormone Factory
• Chifeng Bo-En Pharmaceutical
• Guangzhou Vbio-Pharma
• JALLY
• Ningbo Creator Animal Pharmaceutical

Serum Gonadotrophin for Injection by Segment

The study includes a forecast of the global serum gonadotrophin for injection market by type, application, and region.

Serum Gonadotrophin for Injection Market by Type [Analysis by Value from 2019 to 2031]:

• 1000 IU/Unit
• 5000 IU/Unit
• Others

Serum Gonadotrophin for Injection Market by Application [Analysis by Value from 2019 to 2031]:

• Pig
• Cattle
• Sheep
• Horse
• Others

Serum Gonadotrophin for Injection Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Serum Gonadotrophin for Injection Market

The serum gonadotrophin for injection market has seen significant progress recently across major global regions. This growth is attributed to the increasing availability of fertility treatments, advancements in reproductive health research, and approvals for new formulations. As health care providers seek new methods to manage infertility, the evolving market presents both opportunities and challenges for manufacturers and industry stakeholders.

• United States: In the U.S., the FDA has recently approved several new and revised serum gonadotrophin formulations, which will assist patients seeking fertility treatments. With increased awareness of reproductive health and a growing number of assisted reproductive technology (ART) clinics, the market continues to expand. Additionally, telehealth is facilitating easier access to these therapies for patients.
• China: The serum gonadotrophin market in China is rapidly growing due to rising infertility rates and government support for reproductive health programs. Increased collaboration between local manufacturers and international companies is enabling the development of new gonadotrophin therapies. Furthermore, advancements in the country's healthcare system are improving the availability and affordability of fertility services.
• Germany: In recent years, there has been a gradual increase in the use of serum gonadotrophin injections in German fertility clinics. The government is focusing on product development to enhance performance, with many clinical studies underway. Moreover, public awareness programs about fertility treatments have led to a higher uptake of serum gonadotrophins.
• India: The serum gonadotrophin market in India is growing quickly due to rising infertility rates and an expanding middle class. Manufacturers are launching more affordable brands and formulations to make treatment accessible to a broader patient base. Collaboration between healthcare providers and the pharmaceutical sector is also improving patient access to these medications.
• Japan: The serum gonadotrophin market in Japan is highly regulated, focusing on innovative therapies. With the introduction of biosimilar gonadotrophins, the market is expected to see increased competition and reduced treatment costs. Advances in fertility treatment are also contributing to the adoption of serum gonadotrophin injections.

Features of the Global Serum Gonadotrophin for Injection Market

Market Size Estimates: Serum gonadotrophin for injection market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Serum gonadotrophin for injection market size by type, application, and region in terms of value ($B).

Regional Analysis: Serum gonadotrophin for injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the serum gonadotrophin for injection market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the serum gonadotrophin for injection market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the serum gonadotrophin for injection market by type (1000 IU/unit, 5000 IU/unit, and others), application (pig, cattle, sheep, horse, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Serum Gonadotrophin for Injection Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Serum Gonadotrophin for Injection Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Serum Gonadotrophin for Injection Market by Type
  • 3.3.1: 1000 IU/Unit
  • 3.3.2: 5000 IU/Unit
  • 3.3.3: Others
• 3.4: Global Serum Gonadotrophin for Injection Market by Application
  • 3.4.1: Pig
  • 3.4.2: Cattle
  • 3.4.3: Sheep
  • 3.4.4: Horse
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Serum Gonadotrophin for Injection Market by Region
• 4.2: North American Serum Gonadotrophin for Injection Market
  • 4.2.1: North American Market by Type: 1000 IU/Unit, 5000 IU/Unit, and Others
  • 4.2.2: North American Market by Application: Pig, Cattle, Sheep, Horse, and Others
• 4.3: European Serum Gonadotrophin for Injection Market
  • 4.3.1: European Market by Type: 1000 IU/Unit, 5000 IU/Unit, and Others
  • 4.3.2: European Market by Application: Pig, Cattle, Sheep, Horse, and Others
• 4.4: APAC Serum Gonadotrophin for Injection Market
  • 4.4.1: APAC Market by Type: 1000 IU/Unit, 5000 IU/Unit, and Others
  • 4.4.2: APAC Market by Application: Pig, Cattle, Sheep, Horse, and Others
• 4.5: ROW Serum Gonadotrophin for Injection Market
  • 4.5.1: ROW Market by Type: 1000 IU/Unit, 5000 IU/Unit, and Others
  • 4.5.2: ROW Market by Application: Pig, Cattle, Sheep, Horse, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities of the Global Serum Gonadotrophin for Injection Market by Type
  • 6.1.2: Growth Opportunities of the Global Serum Gonadotrophin for Injection Market by Application
  • 6.1.3: Growth Opportunities of the Global Serum Gonadotrophin for Injection Market by Region
• 6.2: Emerging Trends in the Global Serum Gonadotrophin for Injection Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Serum Gonadotrophin for Injection Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Serum Gonadotrophin for Injection Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: MSD Animal Health
• 7.2: Ceva Sante Animale
• 7.3: Syntex
• 7.4: Bioveta
• 7.5: Ningbo Sansheng Biological Technology
• 7.6: Ningbo Second Hormone Factory
• 7.7: Chifeng Bo-En Pharmaceutical
• 7.8: Guangzhou Vbio-Pharma
• 7.9: JALLY
• 7.10: Ningbo Creator Animal Pharmaceutical